Wisp is entering its next phase of growth with a significantly expanded women’s health platform covering fertility, menopause, diagnostics, longevity and other health needs, alongside the sexual and reproductive care that established the company.
The company announced the milestone on 15 September 2026 together with the appointment of Keira Krausz as its new CEO. Krausz succeeds Monica Cepak and brings experience in direct-to-consumer businesses, including her previous role as Chief Marketing Officer at Purple.
The leadership change comes as Wisp seeks to evolve from an episodic telehealth service into a healthcare platform that can support women across multiple stages of their lives.
From reproductive care to a broader health platform
Wisp was established around accessible online treatment for sexual and reproductive health, including conditions such as urinary tract infections and sexually transmitted infections.
Over the past eight years, the company has built its model around 24/7 telehealth and discreet access to care. It now says it has supported more than 2 million patients across the US.
The next stage is considerably broader.
Wisp is expanding into fertility, preventive diagnostics, menopause, perimenopause, longevity and healthy ageing, alongside areas including mitochondrial and cognitive health and skincare. The company has also recently expanded into weight management and longevity care involving prescription peptides.
Its current offering already includes at-home testing and diagnostics, PCOS support, menopause care, migraine care, vaginal probiotics and longevity and healthy ageing services.
The strategy reflects a shift from treating individual healthcare needs to creating a platform that women can return to throughout different stages of their lives.
Keira Krausz takes the helm
Krausz brings a direct-to-consumer background to the company’s expansion.
Before joining Wisp, she served as Chief Marketing Officer at Purple, the consumer mattress and wellness brand. Her career has centred on building and scaling consumer-facing businesses, making the transition to Wisp’s next stage particularly relevant as the company seeks to make healthcare more accessible and easier to navigate.
Krausz told MobiHealthNews that the company’s patients had been asking for support in areas beyond its original sexual and reproductive health offering, particularly fertility, perimenopause, menopause and longevity.
That feedback is now shaping the company’s expansion.
Wisp’s ambition is to become what Krausz describes as a trusted, always-available healthcare destination for women rather than a service used only when a specific health issue arises.
Building around different stages of women’s lives
The expansion comes at a time when digital women’s health companies are increasingly moving beyond individual categories.
Wisp’s new model brings together telehealth, at-home diagnostics, prescription treatments and personalised care within a single platform. The company says it is designed to support women from reproductive health through later-life health needs.
That approach also creates a broader commercial opportunity.
Instead of relying solely on individual treatments or one-off consultations, Wisp can build longer-term relationships with patients as their healthcare needs change. Fertility, menopause, healthy ageing and chronic or preventative care can each represent different points of engagement within the same platform.
For a company that has already reached 2 million patients, the expansion provides an established customer base from which to develop those additional services.
The next chapter for women’s telehealth
Wisp’s evolution reflects a wider shift in digital healthcare, where companies are attempting to move from narrowly defined services towards more integrated healthcare platforms.
The challenge will be balancing that expansion with clinical quality, patient trust and the specialised requirements of different areas of women’s health.
For Wisp, however, the direction is clear. After eight years building a recognised position in sexual and reproductive telehealth, the company is now attempting to create a broader healthcare destination for women.
With Krausz taking over as CEO and the patient base surpassing 2 million, Wisp enters its next chapter with ambitions that extend well beyond the category in which it began.
